RICHARD HENRY LOGAN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health OAK PARK, IL NPI 1043085871
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health IL Axsome Therapeutics, Inc. All categories
General Payments — all program years on this page
$312.66
- Category: General Payments
- Program years: PY2023–2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $293.32 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $293.32 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Axsome Therapeutics, Inc. | $93.29 | 1 |
| Janssen Pharmaceuticals, Inc | $86.62 | 1 |
| Neurocrine BioSciences, Inc. | $46.05 | 2 |
| Indivior Inc. | $28.00 | 1 |
| Almatica Pharma Inc. | $25.07 | 1 |
| Neos Therapeutics, LP | $14.29 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078011748 | Janssen Pharmaceuticals, Inc | $86.62 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1082671055 | Neos Therapeutics, LP | $14.29 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137604847 | Almatica Pharma LLC | $25.07 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144560803 | Indivior Inc. | $28.00 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148403351 | Axsome Therapeutics, Inc. | $93.29 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150943161 | Neurocrine Biosciences, Inc. | $28.68 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150992958 | Neurocrine Biosciences, Inc. | $17.37 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.